Peripheral Neuropathies Clinical Trials

6 recruitingLast updated: June 18, 2026

There are 6 actively recruiting peripheral neuropathies clinical trials across 5 countries. Studies span Not Applicable. Top locations include Boston, Massachusetts, United States, Brno, Czech Republic, Czechia, Cayenne, French Guiana. Updated daily from ClinicalTrials.gov.


Peripheral Neuropathies Trials at a Glance

6 actively recruiting trials for peripheral neuropathies are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Boston, Brno, and Cayenne. Lead sponsors running peripheral neuropathies studies include Admin CIC, Dana-Farber Cancer Institute, and Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta.

Browse peripheral neuropathies trials by phase

About Peripheral Neuropathies Clinical Trials

Looking for clinical trials for Peripheral Neuropathies? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Peripheral Neuropathies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Peripheral Neuropathies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathy With Type 2 DiabetesPeripheral Neuropathies+2 more
RxFunction Inc.200 enrolled6 locationsNCT06959277
Recruiting
Not Applicable

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Chemotherapy-induced Peripheral Neuropathy (CIPN)NeuropathyPeripheral Neuropathy Due to Chemotherapy+1 more
Dana-Farber Cancer Institute21 enrolled1 locationNCT06807294
Recruiting
Not Applicable

Environmental Factors Associated With Peripheral Neuropathies in French Guiana

Peripheral NeuropathiesEnvironmental Risk FactorLead Neuropathy+2 more
Admin CIC78 enrolled2 locationsNCT07341997
Recruiting

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

Peripheral NeuropathiesAmyotrophic Lateral Sclerosis(ALS)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta400 enrolled4 locationsNCT07268833
Recruiting

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

Neuromuscular Diseases (NMD)PolyneuropathiesPeripheral Neuropathies+4 more
Masaryk University70 enrolled2 locationsNCT07166302
Recruiting

This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

Waldenstrom MacroglobulinaemiaPeripheral Neuropathies
Rigshospitalet, Denmark90 enrolled1 locationNCT07160270